HIGHLIGHTS
- who: Enhanced Tumor, Targeting and Federico, Perche from the Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, the Fenway, Room, Huntington Boston, MA, USA have published the paper: Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting, in the Journal: (JOURNAL) of 25/Dec/2012
SUMMARY
Liposomes, first described in 1965, are established drug and gene delivery carriers with clinical evidence of efficacy and several commercially available approved clinical formulations. As recently reviewed, the most important property of liposomal nanocarriers is protection from the degradation and optimization of the pharmacokinetics of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.